Clinical Trial Update: Blinatumomab Maintenance After Allo-HSCT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating blinatumomab as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with high-risk a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Ruijin Hospital | Conditions: High Risk Acute Lymphoblastic Leukemia | Phase 2 | Status: NOT_YET_RECRUITING